The phosphodiesterase 8B Gene rs4704397 is associated with thyroid function, risk of myocardial infarction, and body height: The Tromsø study

Thyroid

Volumn 24, Issue 2, 2014, Pages 215-222

  Jorde, Rolf ^a,b   Schirmer, Henrik ^a   Wilsgaard, Tom ^a   Joakimsen, Ragnar Martin ^a,b   Mathiesen, Ellisiv Bøgeberg ^a   Njølstad, Inger ^a   Løchen, Maja Lisa ^a   Figenschau, Yngve ^a   Svartberg, Johan ^a,b   Hutchinson, Moira Strand ^a   Kjærgaard, Marie ^a,b   Jørgensen, Lone ^a   Grimnes, Guri ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

3',5'-CYCLIC-AMP PHOSPHODIESTERASES; ADULT; AGED; BODY HEIGHT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; THYROID DISEASES; THYROID GLAND; THYROXINE; TRIIODOTHYRONINE;

EID: 84894176205     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0177     Document Type: Article

References (40)

1. Yen PM 2001 Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097-1142.
2. Becker C 1985 Hypothyroidism and atherosclerotic heart disease: pathogenesis, medical management, and the role of coronary artery bypass surgery. Endocr Rev 6:432-440.
3. Rodondi N, Den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT, Vanderpump MP, Newman AB, Cornuz J, Franklyn JA, Westendorp RG, Vittinghoff E, Gussekloo J 2010 Thyroid Studies Collaboration. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304:1365-1374.
4. Asvold BO, Bjøro T, Nilsen TI, Gunnell D, Vatten LJ 2008 Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study. Arch Intern Med 168:8558-8560.
5. Iqbal A, Jorde R, Figenschau Y 2006 Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study. J Intern Med 260:53-61.
6. Asvold BO, Vatten LJ, Nilsen TI, Bjøro T 2007 The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol 156:181-186.
7. Nyrnes A, Jorde R, Sundsfjord J 2006 Serum TSH is positively associated with BMI. Int J Obes 30:100-105.
8. Svare A, Nilsen TI, Bjøro T, Asvold BO, Langhammer A 2011 Serum TSH related to measures of body mass: longitudinal data from the HUNT Study, Norway. Clin Endocrinol 74:769-775.
9. Iqbal A, Figenschau Y, Jorde R 2006 Blood pressure in relation to serum thyrotropin: the Tromsø Study. J Hum Hypertens 20:932-936.
10. Rawal R, Teumer A, Völzke H, Wallaschofski H, Ittermann T, Åsvold BO, Bjøro T, Greiser KH, Tiller D, Werdan K, Zu Schwabedissen HE, Doering A, Illig T, Gieger C, Meisinger C, Homuth G 2012 Meta-analysis of two genome-wide association studies identifies four genetic loci associated with thyroid function. Hum Mol Genet 21:3275-3282.
11. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Masson G, He H, Jonasdottir A, Sigurdsson A, Stacey SN, Johannsdottir H, Helgadottir HT, Li W, Nagy R, Ringel MD, Kloos RT, De Visser MC, Plantinga TS, Den Heijer M, Aguillo E, Panadero A, Prats E, Garcia-Castanõ A, De Juan A, Rivera F, Walters GB, Bjarnason H, Tryggvadottir L, Eyjolfsson GI, Bjornsdottir US, Holm H, Olafsson I, Kristjansson K, Kristvinsson H, Magnusson OT, Thorleifsson G, Gulcher JR, Kong A, Kiemeney LA, Jonsson T, Hjartarson H, Mayordomo JI, Netea-Maier RT, De La Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Rafnar T, Stefansson K 2012 Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet 44:319-322.
12. Porcu E, Medici M, Pistis G, Volpato CB, Wilson SG, Cappola AR, Bos SD, Deelen J, Den Heijer M, Freathy RM, Lahti J, Liu C, Lopez LM, Nolte IM, O'Connell JR, Tanaka T, Trompet S, Arnold A, Bandinelli S, Beekman M, Böhringer S, Brown SJ, Buckley BM, Camaschella C, De Craen AJ, Davies G, De Visser MC, Ford I, Forsen T, Frayling TM, Fugazzola L, Gögele M, Hattersley AT, Hermus AR, Hofman A, Houwing-Duistermaat JJ, Jensen RA, Kajantie E, Kloppenburg M, Lim EM, Masciullo C, Mariotti S, Minelli C, Mitchell BD, Nagaraja R, Netea-Maier RT, Palotie A, Persani L, Piras MG, Psaty BM, Räikkönen K, Richards JB, Rivadeneira F, Sala C, Sabra MM, Sattar N, Shields BM, Soranzo N, Starr JM, Stott DJ, Sweep FC, Usala G, Van Der Klauw MM, Van Heemst D, Van Mullem A, Vermeulen SH, Visser WE, Walsh JP, Westendorp RG, Widen E, Zhai G, Cucca F, Deary IJ, Eriksson JG, Ferrucci L, Fox CS, Jukema JW, Kiemeney LA, Pramstaller PP, Schlessinger D, Shuldiner AR, Slagboom EP, Uitterlinden AG, Vaidya B, Visser TJ, Wolffenbuttel BH, Meulenbelt I, Rotter JI, Spector TD, Hicks AA, Toniolo D, Sanna S, Peeters RP, Naitza S 2013 A meta-analysis of thyroid-related traits reveals novel Loci and gender-specific differences in the regulation of thyroid function. PLoS Genet 9:e1003266.
13. Arnaud-Lopez L, Usala G, Ceresini G, Mitchell BD, Pilia MG, Piras MG, Sestu N, Maschio A, Busonero F, Albai G, Dei M, Lai S, Mulas A, Crisponi L, Tanaka T, Bandinelli S, Guralnik JM, Loi A, Balaci L, Sole G, Prinzis A, Mariotti S, Shuldiner AR, Cao A, Schlessinger D, Uda M, Abecasis GR, Nagaraja R, Sanna S, Naitza S 2008 Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. Am J Hum Genet 82:1270-1280.
14. Taylor PN, Panicker V, Sayers A, Shields B, Iqbal A, Bremner AP, Beilby JP, Leedman PJ, Hattersley AT, Vaidya B, Frayling T, Evans J, Tobias JH, Timpson NJ, Walsh JP, Dayan CM 2011 A meta-analysis of the associations between common variation in the PDE8B gene and thyroid hormone parameters, including assessment of longitudinal stability of associations over time and effect of thyroid hormone replacement. Eur J Endocrinol 164:773-780.
15. Shields BM, Freathy RM, Knight BA, Hill A, Weedon MN, Frayling TM, Hattersley AT, Vaidya B 2009 Phosphodiesterase 8B gene polymorphism is associated with subclinical hypothyroidism in pregnancy. J Clin Endocrinol Metab 94:4608-4612.
16. Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njølstad I 2012 Cohort profile: the Tromso Study. Int J Epidemiol 41:961-967.
17. Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Figenschau Y, Jenssen T, Njølstad I, Schirmer H, Jorde R 2010 Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up. Diabet Med 27:1107-1115.
18. Jorde R, Schirmer H, Wilsgaard T, Joakimsen RM, Mathiesen EB, Njølstad I, Løchen ML, Figenschau Y, Berg JP, Svartberg J, Grimnes G 2012 Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study. PLoS One 7:e37295.
19. Kulathinal S, Karvanen J, Saarela O, Kuulasmaa K 2007 Case-cohort design in practice-experiences from the MORGAM Project. Epidemiol Perspect Innov 4:15.
20. Joseph J, Svartberg J, Njølstad I, Schirmer H 2011 Risk factors of type 2 diabetes in groups stratified according to metabolic syndrome. A 10-year follow-up of The Tromsø Study. Eur J Epidemiol 26:117-124.
21. Mannsverk J, Wilsgaard T, Njølstad I, Hopstock LA, Løchen ML, Mathiesen EB, Thelle DS, Rasmussen K, Bønaa KH 2012 Age and gender differences in incidence and case fatality trends for myocardial infarction: a 30-year follow-up. The Tromso Study. Eur J Prev Cardiol 19:927-934.
22. Grimnes G, Joakimsen R, Figenschau Y, Torjesen PA, Almås B, Jorde R 2012 The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass-a randomized controlled 1-year trial. Osteoporosis International 23:201-211.
23. Kjærgaard M, Waterloo K, Wang CE, Almås B, Figenschau Y, Hutchinson MS, Svartberg J, Jorde R 2012 Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial. Br J Psychiatry 201:360-368.
24. Rodriguez S, Gaunt TR, Day IN 2009 Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 169:505-514.
25. Hayashi M, Matsushima K, Ohashi H, Tsunoda H, Murase S, Kawarada Y, Tanaka T 1998 Molecular cloning and characterization of human PDE8B, a novel thyroid-specific isozyme of 3', 5'-cyclic nucleotide phosphodiesterase. Biochem Biophys Res Commun 250:751-756.
26. Persani L, Borgato S, Lania A, Filopanti M, Mantovani G, Conti M, Spada A 2001 Relevant cAMP-specific phosphodiesterase isoforms in human pituitary: effect of Gs (alpha) mutations. J Clin Endocrinol Metab 86:3795-3800.
27. Vassart G, Dumont JE 1992 The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev 13:596-611.
28. Wit JM, Camacho-Hübner C 2011 Endocrine regulation of longitudinal bone growth. Endocr Dev 21:30-41.
29. Monzani A, Prodam F, Rapa A, Moia S, Agarla V, Bellone S, Bona G 2012 Endocrine disorders in childhood and adolescence. Natural history of subclinical hypothyroidism in children and adolescents and potential effects of replacement therapy: a review. Eur J Endocrinol 168:R1-R11.
30. Lettre G 2009 Genetic regulation of adult stature. Curr Opin Pediatr 21:515-522.
31. Gudbjartsson DF, Walters GB, Thorleifsson G, Stefansson H, Halldorsson BV, Zusmanovich P, Sulem P, Thorlacius S, Gylfason A, Steinberg S, Helgadottir A, Ingason A, Steinthorsdottir V, Olafsdottir EJ, Olafsdottir GH, Jonsson T, Borch-Johnsen K, Hansen T, Andersen G, Jorgensen T, Pedersen O, Aben KK, Witjes JA, Swinkels DW, Den Heijer M, Franke B, Verbeek AL, Becker DM, Yanek LR, Becker LC, Tryggvadottir L, Rafnar T, Gulcher J, Kiemeney LA, Kong A, Thorsteinsdottir U, Stefansson K 2008 Many sequence variants affecting diversity of adult human height. Nat Genet 40:609-615.
32. Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, Nyholt DR, Madden PA, Heath AC, Martin NG, Montgomery GW, Goddard ME, Visscher PM 2010 Common SNPs explain a large proportion of the heritability for human height. Nat Genet 42:565-569.
33. Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM 2001 Height, leg length, and cancer risk: a systematic review. Epidemiol Rev 23:313-342.
34. Njølstad I, Arnesen E, Lund-Larsen PG 1996 Body height, cardiovascular risk factors, and risk of stroke in middle-aged men and women. A 14-year follow-up of the Finnmark Study. Circulation 94:2877-2882.
35. Jousilahti P, Tuomilehto J, Vartiainen E, Eriksson J, Puska P 2000 Relation of adult height to cause-specific and total mortality: a prospective follow-up study of 31, 199 middleaged men and women in Finland. Am J Epidemiol 151:1112-1120.
36. Asvold BO, Bjøro T, Platou C, Vatten LJ 2012 Thyroid function and the risk of coronary heart disease: 12-year follow-up of the HUNT study in Norway. Clin Endocrinol 77:911-917.
37. Sheehan NA, Didelez V, Burton PR, Tobin MD 2008 Mendelian randomisation and causal inference in observational epidemiology. PLoS Med 5:e177.
38. Grandone A, Perrone L, Cirillo G, Di Sessa A, Corona AM, Amato A, Cresta N, Romano T, Miraglia Del Giudice E 2012 Impact of phosphodiesterase 8B gene rs4704397 variation on thyroid homeostasis in childhood obesity. Eur J Endocrinol 166:255-260.
39. Klein I, Danzi S 2007 Thyroid disease and the heart. Circulation 116:1725-1735.
40. Broderstad AR, Smith-Sivertsen T, Dahl IM, Ingebretsen OC, Lund E 2010 Low prevalence of hereditary hemochromatosis in multiethnic populations in Northern Norway. Scand J Gastroenterol 46:350-357.